SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 15.18 |
| Enterprise Value ($M) | 48.65 |
| Book Value ($M) | -21.67 |
| Book Value / Share | -3.10 |
| Price / Book | -0.70 |
| NCAV ($M) | -36.55 |
| NCAV / Share | -5.23 |
| Price / NCAV | -0.42 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.09 |
| Return on Assets (ROA) | -0.05 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.23 |
| Current Ratio | 6.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27.94 |
| Assets | 42.81 |
| Liabilities | 64.48 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 0.00 | -100.00 | |
| 13G/A | Federated Hermes, Inc. | 19.32 | 12.49 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,530 | 26,594 | 17.03 | |
| 1,085 | 17,333 | 6.26 | |
| 57 | 4,865 | 1.17 | |
| 795 | 6,406 | 12.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MTEX – Mannatech, Incorporated | MYNZ – Mainz Biomed N.V. |
| NATR – Nature's Sunshine Products, Inc. | NKTR – Nektar Therapeutics |
| NLSP – NLS Pharmaceutics AG |
Financial data and stock pages provided by
Fintel.io